background image

Paid Clinical Trials Tennessee

Discover 1,773 paid clinical trials in Tennessee. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Active & ResponsiveNew

Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC

for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Nashville TN
Sponsor: Vandana Abramson

Sex: All

Age: 18+

Code: NCT07016399

Phase2, Recruiting
Active & ResponsiveNew

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

for
Non-muscle Invasive Bladder Cancer
Location: Nashville TN, Myrtle Beach SC
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07206225

Phase1, Recruiting
Active & Responsive

A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors

for
Cervical Cancer,
Location: Nashville TN, Iowa City IA, Hamilton, Houston TX,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT04895709

Phase1, Phase2, Recruiting
Active & Responsive

A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Nashville TN, Birmingham AL, Athens GA, Chicago IL,
Sponsor: Celgene

Sex: Male

Age: 18+

Code: NCT06764485

Phase3, Recruiting
Active & Responsive

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab

for
Relapsing Multiple Sclerosis (RMS)
Location: Birmingham AL, Knoxville TN, Cordova TN, Atlanta GA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06869785

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)

for
Solid Tumors, Gastric Cancer,
Location: Memphis TN, Greenville SC, Fairfax VA, Houston TX,
Sponsor: EMD Serono Research & Development Institute, Inc.

Sex: All

Age: 18+

Code: NCT06710132

Phase1, Phase2, Recruiting
Active & Responsive

Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)

for
Tachycardia, Ventricular
Location: Nashville TN, Saint Louis MO, Columbus OH,
Sponsor: Varian, a Siemens Healthineers Company

Sex: All

Age: 18+

Code: NCT05765175

Recruiting
Active & Responsive

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

for
Small Cell Lung Cancer
Location: Nashville TN, Chicago IL, Milwaukee WI, Buffalo NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06780137

Phase1, Phase2, Recruiting
Active & Responsive

Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors

for
Childhood Cancer, Muscle Weakness
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 18+

Code: NCT06819475

Recruiting
Active & Responsive

BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas

for
Glioblastoma, IDH1 Gene Mutation, IDH2 Gene Mutation,
Location: Memphis TN, St Louis MO, Durham NC, Baltimore MD,
Sponsor: University of California, San Francisco

Sex: All

Age: 13 - 39

Code: NCT03749187

Phase1, Recruiting

Popular cities in Tennessee

MurfreesboroChattanoogaKnoxvilleNashvilleMemphis